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490a Tuesday, February 28, 2012is stretched beyond a certain limit by molecular binding, it might become leaky
to small molecules. We believe that this complicated concentration-dependent
permeation rate could be a common pattern for amphipathic drugs.
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HIV-1 fusion inhibitor peptides bind to gp41 and prevent its fusogenic confor-
mation, inhibiting the initial step of viral entry into host cells. This early action
suggests that these inhibitors can become new microbicide candidates. Enfuvir-
tide remains the only fusion inhibitor approved for clinical use. We studied the
membrane interaction of a recent, highly potent, fusion inhibitor conjugate,
C34-cholesterol (L’644), and compared it with other unconjugated peptides
in order to better understand their mode of action. Large unilamellar vesicles
were used to quantify the partition of the peptides using its intrinsic tryptophan
fluorescence as a reporter. We confirmed that C34 has residual partition to-
wards lipid membranes, except for DPPC, and observed that the conjugated
peptide presents high partition. For cell membranes studies, isolated human pe-
ripheral blood mononuclear cells (PBMC) and erythrocytes were label with di-
8-ANEPPS. This fluorescent probe is sensitive to dipole potential changes at
the membrane level and can report the association of drugs to the cell mem-
brane. C34 and cholesterol itself did not change membrane dipole potential sig-
nificantly, in sharp contrast with the conjugated peptide that presented
membrane affinity 115-fold higher than enfuvirtide and 14-fold higher than
T-1249 for PBMC. Similar behavior was observed for erythrocytes. The high
membranotropism of C34-cholesterol compared to the almost non existing
binding of C34 and no effect of cholesterol itself in cells, suggests a synergistic
potentiating effect when the two components are present in the conjugated mol-
ecule. Membrane binding can be a more efficient route than simple aqueous dif-
fusion to facilitate the binding of the inhibitor to the pre-fusion conformation of
gp41. Moreover, such a high binding to cell surface is an advantageous factor
for the drug to be used as a topical microbicide.
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Enfuvirtide (FDA-approved) and T-1249 (second-generation drug) are two po-
tent HIV-1 fusion inhibitor peptides. Recent studies indicate that lipid mem-
branes play an important role in the mode of action of this class of inhibitors.
In this work, we studied the interaction of both peptides with supported lipid
bilayers presenting liquid disordered (ld)-gel (so) and ld-liquid ordered (lo)
phase separations, using atomic force microscopy (AFM) combined with epi-
fluorescence microscopy. In the ld-so lipid system, results indicate an increased
roughness and bilayer thinning at ld domains upon addition of 15mM T-1249
compared to enfuvirtide. Furthermore, T-1249 inserts and disrupts the borders
of so rigid domains, unlike enfuvirtide. In ld-lo lipid bilayers, increased rough-
ness due to membrane solubilisation and thinning is also observed on ld do-
mains for T-1249, but no disruption of the lo domain borders is detectable.
At 1.5mM enfuvirtide and T-1249, the effects on the membrane were less pro-
nounced or even absent.
We further performed fluorescence excitation measurements on ld, lo and so
lipid vesicles using the dipole potential probe di-8-ANEPPS. In agreement
with previous experiments, T-1249 promotes a higher decrease in the dipole
potential of ld and lo lipid vesicles and an increased affinity for so vesicles
in comparison to enfuvirtide.
Since T-1249 possess both tryptophan-rich (TRD) and pocket-binding (PBD)
hydrophobic domains at both ends, in contrast to enfuvirtide that only yields
the C-terminal TRD, our results indicate that the increase in membrane tropism
may be due to a cooperation of both domains on the peptide. Those findings
help to explain the improved inhibition efficiency of T-1249, by providing a lo-
cal increased peptide concentration near the fusion site, and provide valuable
insights for the development of more potent HIV-1 inhibitors.
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University of California, Irvine, CA, USA.The transfer of peptide segments into the lipid bilayer to form stable transmem-
brane helices is the crucial first step in membrane protein folding and assembly.
However, the mechanisms that drive this process are not fully understood. A
recent experimental assay has measured the insertion of designed peptide se-
quences into the endoplasmic reticulum membrane via the cellular translocon
machinery. This has provided the first quantitative estimate of the
translocon-to-membrane transfer free-energy of polypeptide segments. How-
ever, no suitable experimental setup currently exists that allows the direct mea-
surement of the free-energy change involved in transferring peptides from
water into lipid bilayers. This is because peptides that are sufficiently hydro-
phobic to insert into membranes tend to aggregate in solution.
We have developed an experimental setup that directly measures the water-to-
bilayer partitioning of a series of systematically designed peptides that do not
have this problem. These were derived by re-engineering of a peptide called
pHLIP, which is based on helix C of bacteriorhodopsin. The peptides have
a set of unique properties; they are soluble at neutral pH and spontaneously in-
sert into lipid bilayers when the pH is lowered. The peptides are monomeric
both in solution at neutral pH and in the bilayer at low pH, allowing direct de-
termination of their partitioning free energy. We compare the results with con-
verged atomic detail simulations of the adsorption, folding, and insertion of
these peptides into lipid bilayers under conditions identical to the experiment.
Direct experimental measurement of peptide partitioning free energies is highly
desirable for the development and calibration of hydrophobicity scales and
computer simulation models, which rely crucially on accurate transfer free en-
ergies between water and membranes. Research supported by NIH grants
GM74637 and GM86685 to S.H.W. M.B.U. was supported by a Marie Curie
International Fellowship.
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The folding and assembly of a-helical integral membrane proteins into func-
tional molecules is largely mediated by the lateral interactions of its transmem-
brane (TM) a-helices where sequence motifs often maximize van der Waals
packing and/or polar interactions at sites of helix-helix contact. These interac-
tions play a major role in determining the correct formation of tertiary and qua-
ternary structure for these hydrophobic proteins. We have previously shown
that a Lys-tagged TM2 a-helix of myelin proteolipid protein (PLP), of parent
sequence, KKKK-AFQYVIYGTASFFFLYGALLLAEGF-KKKK, is capable
of self-dimerization in the membrane mimetic detergent sodium dodecylsulfate
(SDS). In the present work, we use protein gel electrophoresis, circular dichro-
ism, and fluorescence resonance energy transfer to demonstrate that the oligo-
meric state of this peptide can be modulated by pH. Specifically, as the pH is
increased, the peptide shifts from dimer to monomer. Mutational analysis re-
veals that this functionality is due to the C-terminal glutamic acid. Our overall
results emphasize the potential influence of surrounding residues on the inter-
action strength of TM helix-helix contact sites that mediate oligomerization and
may have implications for the control of biologically relevant events involving
helix-helix interactions in some membrane proteins.
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A theoretical approach to large-scale modeling of a-helices inmicelles and lipid
bilayers has been developed. The FMAP (Folding of Membrane-Associated
Peptides) method identifies potential a-helices in amino acid sequences of pep-
tides and proteins, calculates their thermodynamic stability and membrane-
binding affinity, and provides full-atomic 3D models arranged with respect to
membranes. The method accounts for: (a) backbone enthalpic and entropic con-
tributions and side chain secondary structure propensities, as described by a ther-
modynamicmodel of helix-coil transition (Framework1); (b) transfer free energy
ofa-helical and coil segments fromwater to anisotropicmembrane environment
(including the long-range electrostatics and first-shell solvation components), as
described by implicit solvent model of the lipid bilayer (PPM2); and (c) van der
Waals interactions and H-bonds between side chains, as defined by interatomic
potentials derived from protein engineering data3,4. FMAP was thoroughly
tested for more than a hundred of experimentally studied peptides. It was subse-
quently applied for modeling of transmembrane a-helical segments in ~2500
single-spanning proteins from the entire human proteome. The results of the cal-
culations are available in the Membranome database at membranome.org.
1. Lomize AL, Mosberg HI. Thermodynamic model of secondary structure for
alpha-helical peptides and proteins. Biopolymers 1997, 42:239-269.
